Ashley Easter, Head of Strategy and Partnerships, Global Oncology Diagnostics at AstraZeneca, shared a post on LinkedIn:
“I’m hiring! We are looking for a dynamic, experienced, and well-connected leader to develop our commercial AI and multimodal diagnostic strategy. Come and join our AstraZeneca Global Oncology Diagnostics Strategy team!
We anticipate rapid advancements in and utility for AI and multimodal diagnostic tools in oncology, so we are thinking ahead to how these will be implemented in oncology clinical practice. This person will be responsible for developing our commercial AI and multimodal biomarker/diagnostic platform strategy – including elements such as deployment of CDx/SaMD, integration of multiple modes of data, and understanding fragmented hospital ecosystems.
The role will be based in either of our main hubs in Gaithersburg, MD or Cambridge, UK.”
More posts featuring AstraZeneca on OncoDaily.